Related Experiment Video
Updated: Oct 20, 2025

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3
Wenwen Zhang1, Zhenling Ma1, Yaru Wu1
1College of Life Sciences, Henan Agricultural University, Zhengzhou 450002, China.
Abstract:
The prevalence of SARS-CoV-2 is a great threat to global public health. However, the relationship between the viral pathogen SARS-CoV-2 and host innate immunity has not yet been well studied. The genome of SARS-CoV-2 encodes a viral protease called 3C-like protease. This protease is responsible for cleaving viral polyproteins during replication. In this investigation, 293T cells were transfected with SARS-CoV-2 3CL and then infected with Sendai virus (SeV) to induce the RIG-I like receptor (RLR)-based immune pathway. q-PCR, luciferase reporter assays, and western blotting were used for experimental analyses. We found that SARS-CoV-2 3CL significantly downregulated IFN-β mRNA levels. Upon SeV infection, SARS-CoV-2 3CL inhibited the nuclear translocation of IRF3 and p65 and promoted the degradation of IRF3. This effect of SARS-CoV-2 3CL on type I IFN in the RLR immune pathway opens up novel ideas for future research on SARS-CoV-2.
Insights
The SARS-CoV-2 3C-like protease suppresses host innate immunity by downregulating interferon-beta (IFN-β) and inhibiting key immune signaling proteins, impacting viral replication and host defense.
Area of Science:
- Virology and Immunology
- Molecular Biology
- Infectious Diseases
Background:
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses a significant global health risk.
- The interaction between SARS-CoV-2 and the host's innate immune system remains incompletely understood.
- SARS-CoV-2 encodes a 3C-like protease (3CL) crucial for viral polyprotein processing during replication.
Purpose of the Study:
- To investigate the impact of SARS-CoV-2 3CL on the host's RIG-I like receptor (RLR)-mediated innate immune response.
- To elucidate the molecular mechanisms by which SARS-CoV-2 3CL interferes with antiviral signaling pathways.
Main Methods:
- Transfection of 293T cells with SARS-CoV-2 3CL.
- Infection of transfected cells with Sendai virus (SeV) to activate the RLR pathway.
- Quantitative PCR (q-PCR), luciferase reporter assays, and Western blotting were employed for analysis.
Main Results:
- SARS-CoV-2 3CL significantly downregulated the expression of interferon-beta (IFN-β) mRNA.
- The viral protease inhibited the nuclear translocation of Interferon Regulatory Factor 3 (IRF3) and Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) p65 subunit upon SeV infection.
- SARS-CoV-2 3CL promoted the degradation of IRF3, further compromising the antiviral response.
Conclusions:
- SARS-CoV-2 3CL actively suppresses the type I interferon (IFN) production within the RLR immune pathway.
- This viral protease interferes with critical host antiviral signaling, potentially facilitating viral replication.
- The findings offer new avenues for understanding SARS-CoV-2 pathogenesis and developing therapeutic strategies.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Leaky Scanning
Regulation of the Unfolded Protein Response

